Cairo – The board of directors of Kahira Pharmaceuticals approved the appointment of Adel Taha Abdel Wahab as the company’s Chairman.
The company also named Yasser Ahmed Farghaly as the Managing Director, according to a bourse disclosure on Sunday.
During the first nine months of fiscal year (FY) 2020/2021, Kahira Pharmaceuticals achieved net profits of EGP 102.9 million, up from EGP 92.23 million in the prior-year period.
Source: Mubasher
All Rights Reserved - Mubasher Info © 2005 - 2021 Provided by SyndiGate Media Inc. (Syndigate.info).
Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.
